BVF as of Sept. 30, 2018
Portfolio Holdings for BVF
BVF holds 57 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 8.4 | $96M | 6.3M | 15.20 | |
| Chemocentryx | 7.5 | $86M | 6.8M | 12.64 | |
| Merus N V (MRUS) | 6.8 | $77M | 3.9M | 19.74 | |
| Cytokinetics (CYTK) | 4.5 | $51M | 5.2M | 9.85 | |
| Five Prime Therapeutics | 4.1 | $47M | 3.4M | 13.92 | |
| Blueprint Medicines (BPMC) | 4.1 | $47M | 598k | 78.06 | |
| Infinity Pharmaceuticals (INFIQ) | 3.6 | $41M | 15M | 2.71 | |
| Kura Oncology (KURA) | 3.1 | $35M | 2.0M | 17.50 | |
| Mirati Therapeutics | 3.0 | $34M | 723k | 47.10 | |
| ArQule | 2.9 | $33M | 5.8M | 5.66 | |
| Xencor (XNCR) | 2.9 | $33M | 838k | 38.97 | |
| Pieris Pharmaceuticals (PIRS) | 2.8 | $31M | 5.6M | 5.60 | |
| Biolinerx Ltd-spons | 2.4 | $28M | 26M | 1.07 | |
| Protagonist Therapeutics (PTGX) | 2.4 | $27M | 2.6M | 10.29 | |
| Ionis Pharmaceuticals (IONS) | 2.4 | $27M | 520k | 51.58 | |
| Xoma Corp Del (XOMA) | 2.3 | $26M | 1.5M | 17.57 | |
| Anaptysbio Inc Common (ANAB) | 2.2 | $25M | 250k | 99.77 | |
| Galmed Pharmaceuticals | 2.1 | $24M | 1.8M | 13.58 | |
| Concert Pharmaceuticals I equity | 2.1 | $24M | 1.6M | 14.84 | |
| Forward Pharma A/s | 1.7 | $19M | 8.5M | 2.28 | |
| Dicerna Pharmaceuticals | 1.5 | $18M | 1.2M | 15.26 | |
| Corvus Pharmaceuticals (CRVS) | 1.4 | $16M | 1.9M | 8.58 | |
| Ac Immune Sa (ACIU) | 1.4 | $16M | 2.0M | 8.00 | |
| Immune Design | 1.4 | $16M | 4.7M | 3.45 | |
| Spero Therapeutics (SPRO) | 1.4 | $16M | 1.5M | 10.51 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $15M | 1.2M | 13.20 | |
| Cti Biopharma | 1.3 | $15M | 6.9M | 2.16 | |
| Molecular Templates | 1.3 | $15M | 2.8M | 5.39 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $15M | 1.1M | 13.94 | |
| Replimune Group (REPL) | 1.3 | $15M | 912k | 16.10 | |
| Verastem | 1.3 | $14M | 2.0M | 7.25 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $14M | 609k | 22.11 | |
| Mei Pharma | 1.2 | $13M | 3.1M | 4.31 | |
| Calithera Biosciences | 1.2 | $13M | 2.5M | 5.25 | |
| Spring Bk Pharmaceuticals In | 1.0 | $12M | 953k | 12.05 | |
| Syndax Pharmaceuticals (SNDX) | 0.9 | $10M | 1.2M | 8.08 | |
| Oncomed Pharmaceuticals | 0.8 | $8.6M | 4.0M | 2.12 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.8 | $8.5M | 1.9M | 4.40 | |
| Vbi Vaccines | 0.7 | $7.5M | 3.1M | 2.42 | |
| Contrafect | 0.6 | $7.2M | 3.5M | 2.07 | |
| Albireo Pharma | 0.6 | $7.2M | 219k | 32.96 | |
| Principia Biopharma | 0.6 | $7.0M | 240k | 29.22 | |
| Merrimack Pharma (MACK) | 0.5 | $5.9M | 1.1M | 5.33 | |
| Argenx Se (ARGX) | 0.5 | $5.8M | 77k | 75.84 | |
| Tesaro | 0.5 | $5.5M | 140k | 39.01 | |
| Erytech Pharma Sa | 0.5 | $5.5M | 625k | 8.72 | |
| Genocea Biosciences | 0.4 | $4.1M | 5.3M | 0.78 | |
| Alpine Immune Sciences (ALPN) | 0.4 | $4.1M | 643k | 6.33 | |
| Surface Oncology | 0.3 | $3.9M | 360k | 10.94 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $3.4M | 1.7M | 2.00 | |
| Regulus Therapeutics | 0.2 | $2.7M | 14M | 0.20 | |
| Aduro Biotech | 0.2 | $2.1M | 288k | 7.35 | |
| Vical | 0.2 | $1.8M | 1.3M | 1.37 | |
| Essa Pharma (EPIX) | 0.1 | $1.7M | 577k | 3.00 | |
| Realm Therapeutics | 0.1 | $1.2M | 361k | 3.25 | |
| Loxo Oncology | 0.1 | $699k | 4.1k | 170.95 | |
| Zymeworks | 0.0 | $311k | 20k | 15.70 |
